Save Search

Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document
 Download PDFDownload PDF 

Previous Fragment    Next Fragment

NOTICE

Senators Xenophon and Madigan gave a notice of motion as follows: To move on the next day of sitting—That the following matters be referred to the Community Affairs References Committee for inquiry and report by 21 March 2013:

 (a) the operation of the Pharmaceutical Benefits Scheme price disclosure mechanism;

 (b) the effect of past price disclosure decisions and subsequent price reductions on the supply of chemotherapy drugs such as Docetaxel, particularly in relation to:

  (i) patient access to treatment,

  (ii) cost to pharmacists and suppliers, and

  (iii) cost to the private and public hospital systems;

 (c) the effect of future price disclosure decisions and subsequent price reductions on the supply of chemotherapy drugs, particularly in relation to patient access to treatment; and

 (d) any related matters.